🔗 Share this article

An underground market for unlicensed weight-loss medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Investigational Treatment Gaining Traction Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to message these accounts directly for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with numerous of participants share “before and after” images, injection guides and assertions of next-day British shipping. Sellers promote the drug there before redirecting customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Voice Concerns

Nevertheless, physicians and chemists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could result in individuals administering substances of unknown origin.

Some professionals stated the demand for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the British medical regulations.

Several influencers try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and customer laws, potentially leading to fines, prosecution or imprisonment.

Service Response and Content Elimination

Based on TikTok, the platform has taken down problematic content and prohibited related hashtags and query recommendations. The organization stated it was dedicated to keeping the service safe and investing in enhancing enforcement strategies.

Digital Marketplace Operations

Investigations also discovered communities with up to nine thousand participants selling retatrutide using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, populated with photos of slimming results, positive testimonials and step-by-step guides for preparing or administering at residence.

After moments of entering one group, a vendor posted contact information, where the majority of transactions take place. The vendor sent an guidebook and promised delivery within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.

Product Details and Costs

Inside these groups, messages show black plastic parcels with postal service stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with sterile water, or pre-filled injectors usually sold at £160 for 20mg. When questioned how much time a injector should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A representative for Telegram said it actively monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they cannot confirm. Although the science behind this drug is sound, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she said.

Her team has already encountered patients injured by personal administration from unverified sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may subject patients to possibly significant medical dangers”.